Overview

Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma

Status:
Recruiting
Trial end date:
2028-12-30
Target enrollment:
Participant gender:
Summary
This clinical trial aims to explore and evaluate the efficacy and safety of combined chemotherapy with arsenic trioxide for stage 4/M neuroblastoma.
Phase:
Phase 2
Details
Lead Sponsor:
Yang Li
Treatments:
Arsenic Trioxide